Enovix Corporation Common Stock (NASDAQ: ENVX)
The Complaint alleges that throughout the Class Period, the Company overstated its production capabilities, touting its “meaningful progress” in scaling up its manufacturing facility and being positioned to deliver batteries ahead of competition, despite its continued manufacturing issues. On November 1, 2022, the Company announced its financial results for 3Q2022, disclosing just $8,000 in recognized revenue, that it would be “dialing back” efforts to improve existing manufacturing lines to focus on future manufacturing lines, and that it anticipated producing fewer than one million batteries in 2023. On this news, shares of Enovix plummeted approximately 44%. Then, on January 3, 2023, the Company disclosed that its second production facility and future manufacturing lines would be delayed by several additional months due to equipment failures. On this news, shares of Enovix plummeted an additional 41%, further damaging investors.